文献速递糖尿病

2017年全球1型糖尿病发病与患病病例估算

Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults.
PubMed 文献 · Diabetologia · 2021-10-02

该研究基于IDF Atlas儿童1型糖尿病发病率数据及成人年龄别发病率缩放比例,结合联合国人口与儿童死亡率数据建模,估算2017年全球1型糖尿病发病数为234,710例、患病数为9,004,610例。高收入国家占全球人口17%却贡献49%发病和52%患病病例,亚洲发病和患病数分别占32%和31%。患病病例中0-14岁、15-39岁、40-64岁和65岁以上分别占6%、35%、43%和16%。

要点

  • 2017年全球1型糖尿病发病估算234,710例,患病估算9,004,610例。
  • 高收入国家占全球人口17%,却占49%发病和52%患病病例。
  • 全球患病病例中40-64岁组占比最高(43%),65岁以上占16%。

核心结论

  • 2017年全球1型糖尿病发病估算234,710例,患病估算9,004,610例。
  • 全球1型糖尿病约占估计糖尿病总病例的2%,范围从某些太平洋国家的不足1%到北欧人群的超过15%。
  • 估算值基于敏感性分析可能偏离±15%。

研究设计与样本

  • 利用IDF Atlas中94个国家儿童1型糖尿病发病率数据外推至无数据国家。
  • 成人年龄别发病率通过各成人年龄组相对于儿童发病率的缩放比例获得(仅不到十个国家已知全年龄段成人发病率)。
  • 将年龄别发病率应用于人口估计获得发病病例数;病程从可用数据估计并利用联合国人口数据中各国儿童死亡率差异调整;患病病例数通过建模患病、发病与病程关系得出。
  • 进行敏感性分析以量化替代假设和模型输入的影响。

主要发现

  • 2017年全球1型糖尿病发病估算234,710例,患病估算9,004,610例。
  • 高收入国家占全球人口17%,占全球发病病例49%和患病病例52%。
  • 亚洲占全球人口60%,发病病例占32%、患病病例占31%。
  • 全球患病病例年龄分布:0-14岁占6%,15-39岁占35%,40-64岁占43%,65岁以上占16%。
  • 基于敏感性分析,估算值可能偏离±15%。

临床怎么用

  • 研究结果可为制定1型糖尿病医疗保健和政策管理方法提供信息。
  • 估算值需进一步验证,因数据可获得性和估算方法存在局限与假设。

局限性

  • 数据可获得性有限,尤其成人1型糖尿病发病率仅不到十个国家已知全年龄段数据。
  • 估算方法涉及假设(如成人发病率缩放比例、病程估计与儿童死亡率调整),敏感性分析提示估算值可能偏离±15%。
  • 估算值需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Data on type 1 diabetes incidence and prevalence are limited, particularly for adults. This study aims to estimate global numbers of incident and prevalent cases of type 1 diabetes in 2017 for all age groups, by country and areas defined by income and region. METHODS: Incidence rates of type 1 diabetes in children (available from 94 countries) from the IDF Atlas were used and extrapolated to countries without data. Age-specific incidence rates in adults (only known across full age range for fewer than ten countries) were obtained by applying scaling ratios for each adult age group relative to the incidence rate in children. Age-specific incidence rates were applied to population estimates to obtain incident case numbers. Duration of diabetes was estimated from available data and adjusted using differences in childhood mortality rate between countries from United Nations demographic data. Prevalent case numbers were derived by modelling the relationship between prevalence, incidence and disease duration. Sensitivity analyses were performed to quantify the impact of alternative assumptions and model inputs. RESULTS: Global numbers of incident and prevalent cases of type 1 diabetes were estimated to be 234,710 and 9,004,610, respectively, in 2017. High-income countries, with 17% of the global population, accounted for 49% of global incident cases and 52% of prevalent cases. Asia, which has the largest proportion of the world's population (60%), had the largest number of incident (32%) and prevalent (31%) cases of type 1 diabetes. Globally, 6%, 35%, 43% and 16% of prevalent cases were in the age groups 0-14, 15-39, 40-64 and 65+ years, respectively. Based on sensitivity analyses, the estimates could deviate by ±15%. CONCLUSIONS/INTERPRETATION: Globally, type 1 diabetes represents about 2% of the estimated total cases of diabetes, ranging from less than 1% in certain Pacific countries to more than 15% in Northern European populations in 2017. This study provides information for the development of healthcare and policy approaches to manage type 1 diabetes. The estimates need further validation due to limitations and assumptions related to data availability and estimation methods.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Green A, Hede SM, Patterson CC, et al. Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults. Diabetologia. 2021. PMID: 34599655. doi:10.1007/s00125-021-05571-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。